Membrane proteomic analysis of pancreatic cancer cells

Journal of Biomedical Science

Volumn 17, Issue 1, 2010, Pages

  Liu, Xiaojun ^a   Zhang, Min ^a   Go, Vay Liang W ^b   Hu, Shen ^a,c  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVITY REGULATED CYTOSKELETON ASSOCIATED PROTEIN; ADENYLATE KINASE; ALPHA ENOLASE; ALPHA GLUCOSIDASE; ASPARTATE AMINOTRANSFERASE; CALNEXIN; CD51 ANTIGEN; CYTOCHROME C OXIDASE; DIHYDROLIPOAMIDE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEME OXYGENASE 2; HEXOKINASE 1; LACTATE DEHYDROGENASE; LIPOCORTIN 1; MEMBRANE PROTEIN; PHOSPHOGLYCERATE KINASE; PROTEIN DISULFIDE ISOMERASE; PYRUVATE KINASE; THIOSULFATE SULFURTRANSFERASE; PROTEOME; TUMOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CELL ADHESION; CELL ISOLATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CITRIC ACID CYCLE; ELECTRON TRANSPORT; FATTY ACID METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; ION TRANSPORT; LIPID METABOLISM; LIPID TRANSPORT; LIQUID CHROMATOGRAPHY; METASTASIS; NUCLEOTIDE METABOLISM; OXIDATION REDUCTION REACTION; PANCREAS ADENOCARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DATABASE; PROTEIN EXPRESSION; RESPIRATORY CHAIN; STRUCTURAL PROTEOMICS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; CHEMISTRY; METHODOLOGY; MOLECULAR GENETICS; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; DATABASES, PROTEIN; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 77956489620     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-17-74     Document Type: Article

References (40)

1. Pancreatic neoplasms. OJ Hines HA Reber, Curr Opin Gastroenterol 2004 20 5 452 458 10.1097/00001574-200409000-00006 15689678
2. Focus on pancreas cancer. EM Jaffee RH Hruban M Canto SE Kern, Cancer Cell 2002 2 1 25 28 10.1016/S1535-6108(02)00093-4 12150822
3. A "catastrophic hypothesis" for pancreas cancer progression. FX Real, Gastroenterol 2003 124 7 1958 1964 10.1016/S0016-5085(03)00389-5 (Pubitemid 36666791)
4. Low-dose trimetrexate glucuronate and protracted 5-fluorouracil infusion in previously untreated patients with advanced pancreatic cancer. RG Amado LS Rosen JR Hecht LS Lin PJ Rosen, Ann Oncol 2002 13 4 582 588 10.1093/annonc/ mdf090 12056709
5. A method for the comprehensive proteomic analysis of membrane proteins. CC Wu MJ MacCoss KE Howell JR Yates, Nat Biotech 2003 21 5 532 538 10.1038/nbt819 (Pubitemid 36532018)
6. The application of mass spectrometry to membrane proteomics. CC Wu JR Yates, Nat Biotech 2003 21 3 262 267 10.1038/nbt0303-262 (Pubitemid 36314809)
7. Proteomic analysis of isolated membrane fractions from superinvasive cancer cells. P Dowling P Meleady A Dowd M Henry S Glynn M Clynes, Biochim Biophys Acta 2007 1774 1 93 101 17085086
8. Quantification of Membrane and Membrane-Bound Proteins in Normal and Malignant Breast Cancer Cells Isolated from the Same Patient with Primary Breast Carcinoma. X Liang J Zhao M Hajivandi R Wu J Tao JW Amshey RM Pope, J Proteome Res 2006 5 10 2632 2641 10.1021/pr060125o 17022634
9. Proteomic Analysis of Plasma Membrane from Hypoxia-Adapted Malignant Melanoma. LH Stockwin J Blonder MA Bumke DA Lucas KC Chan TP Conrads HJ Issaq TD Veenstra DL Newton SM Rybak, J Proteome Res 2006 5 11 2996 3007 10.1021/pr0601739 17081051
10. Characterization of a new primary human pancreatic tumor line. MH Tan NJ Nowak R Loor H Ochi AA Sandberg C Lopez JW Pickren R Berjian HO Douglass Jr TM Chu, Cancer Invest 1986 4 1 15 23 10.3109/07357908609039823 3754176
11. Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice. M Tan T Chu, Tumour Biol 1985 6 1 89 98 4023565
12. Phenotype and genotype of pancreatic cancer cell lines. EL Deer J Gonzlez-Hernndez JD Coursen JE Shea J Ngatia CL Scaife MA Firpo SJ Mulvihill, Pancreas 2010 39 4 425 35 10.1097/MPA.0b013e3181c15963 20418756
13. Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. K Nunomura K Nagano C Itagaki M Taoka N Okamura Y Yamauchi S Sugano N Takahashi T Izumi T Isobe, Mol Cell Proteomics 2005 4 12 1968 1976 10.1074/mcp.M500216-MCP200 16176923
14. Proteomic analysis of macrophages: A new way to identify novel cell-surface antigens. L Zhang Y Lun D Yan L Yu W Ma B Du X Zhu, J Immunol Methods 2007 321 1-2 80 85 10.1016/j.jim.2007.01.009 17306824
15. Pancreatic Cancer: Factors Regulating Tumor Development, Maintenance and Metastasis. X Shi H Friess J Kleeff F Ozawa MW Büchler, Pancreatol 2001 1 5 517 524 10.1159/000055854 (Pubitemid 33681754)
16. Hypoxia-Inducible Factors, Stem Cells, and Cancer. B Keith MC Simon, Cell 2007 129 3 465 472 10.1016/j.cell.2007.04.019 17482542
17. Hypoxia and defective apoptosis drive genomic instability and tumorigenesis. DA Nelson TT Tan AB Rabson D Anderson K Degenhardt E White, Genes Dev 2004 18 17 2095 2107 10.1101/gad.1204904 15314031
18. Breaching the Cancer Fortress. P Olson D Hanahan, Science 2009 324 5933 1400 1401 10.1126/science.1175940 19520948
19. Impact of Vascular Endothelial Growth Factor-C and -D Expression in Human Pancreatic Cancer. H Kurahara S Takao K Maemura H Shinchi S Natsugoe T Aikou, Clin Cancer Res 2004 10 24 8413 8420 10.1158/1078-0432.CCR-04-0379 15623620
20. Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis. M Pez-Ribes E Allen J Hudock T Takeda H Okuyama F Vĩals M Inoue G Bergers D Hanahan O Casanovas, Cancer Cell 2009 15 3 220 231 10.1016/j.ccr.2009.01.027 19249680
21. Tumor hypoxia correlates with metastatic tumor growth of pancreatic cancer in an orthotopic murine model1. P Büchler HA Reber RS Lavey J Tomlinson MW Büchler H Friess OJ Hines, J Surg Res 2004 120 2 295 303 10.1016/j.jss.2004.02.014 15234226
22. Identification of pancreatic cancer invasion-related proteins by proteomic analysis. N Walsh N O'Donovan S Kennedy M Henry P Meleady M Clynes P Dowling, Proteome Sci 2009 7 1 3 10.1186/1477-5956-7-3 19216797
23. Proteomic profiling in pancreatic cancer with and without lymph node metastasis. Y Cui J Wu M Zong G Song Q Jia J Jiang J Han, Int J Cancer 2009 124 7 1614 1621 10.1002/ijc.24163 19152423
24. A proteomic approach to the identification of new tPA receptors in pancreatic cancer cells. O Roda C Chiva G Espũa HJ Gabius FX Real P Navarro D Andreu, Proteomics 2006 6 S1 36 S41 10.1002/pmic.200500376 16544279
25. Important role of integrins in the cancer biology. R Rathinam S Alahari, Cancer Metastasis Rev 2010 29 1 223 237 10.1007/s10555-010-9211-x 20112053
26. Promotion of tumor cell migration by extracellular matrix proteins in human pancreatic cancer. E Ryschich A Khamidjanov V Kerkadze MW Buchler M Zoller J Schmidt, Pancreas 2009 38 7 804 810 10.1097/MPA.0b013e3181b9dfda 19893454
27. NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha 3 beta 1 Integrin. Ji Fukushi IT Makagiansar WB Stallcup, Mol Biol Cell 2004 15 8 3580 3590 10.1091/mbc.E04-03-0236 15181153
28. Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. B Künzli P Berberat Z Zhu M Martignoni J Kleeff A Tempia-Caliera M Fukuda A Zimmermann H Friess M Büchler, Cancer 2002 94 1 228 239 10.1002/cncr.10162 11815981
29. Rapamycin, a specific inhibitor of the mammalian target of rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. S Kobayashi T Kishimoto S Kamata M Otsuka M Miyazaki H Ishikura, Cancer Sci 2007 98 5 726 733 10.1111/j.1349-7006.2007.00439.x 17425689
30. Nuclear Functions for Plasma Membrane-Associated Proteins? A Benmerah M Scott V Poupon S Marullo, Traffic 2003 4 8 503 511 12839493
31. Biomarkers in Cancer Staging, Prognosis and Treatment Selection. JA Ludwig JN Weinstein, Nat Rev Cancer 2005 5 11 845 856 10.1038/nrc1739 16239904
32. A Compendium of Potential Biomarkers of Pancreatic Cancer. HC Harsha K Kandasamy P Ranganathan S Rani S Ramabadran S Gollapudi L Balakrishnan SB Dwivedi D Telikicherla LD Selvan R Goel S Mathivanan A Marimuthu M Kashyap RF Vizza RJ Mayer JA Decaprio S Srivastava SM Hanash RH Hruban A Pandey, PLoS Med 2009 6 4 1000046 10.1371/journal.pmed.1000046 19360088
33. Progress on molecular markers of pancreatic cancer. T Grote CD Logsdon, Curr Opin Gastroenterol 2007 23 5 508 514 10.1097/MOG.0b013e3282ba5724 17762556
34. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. X Guo H Friess HU Graber M Kashiwagi A Zimmermann M Korc, Cancer Res 1996 56 4876 4880 8895737
35. New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis. DV Gold DE Modrak Z Ying TM Cardillo RM Sharkey DM Goldenberg, J Clin Oncol 2006 24 2 252 258 10.1200/JCO.2005.02.8282 16344318
36. CEACAM1, a Novel Serum Biomarker for Pancreatic Cancer. DM Simeone B Ji M Banerjee T Arumugam D Li MA Anderson AM Bamberger J Greenson RE Brand V Ramachandran CD Logsdon, Pancreas 2007 34 4 10.1097/MPA.0b013e3180333ae3 17446843
37. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. C Almoguera D Shibata K Forrester J Martin N Arnheim M Perucho, Cell 1988 53 4 549 554 10.1016/0092-8674(88)90571-5 2453289
38. Prospective evaluation of the pancreatic secretion of immunoreactive carcinoembryonic antigen, enzyme, and bicarbonate in patients suspected of having pancreatic cancer. E DiMagno J Malagelada C Moertel V Go, Gastroenterology 1977 73 3 457 461 892342
39. Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the NCI serum bank. RJ Ritts B Del Villano V Go R Herberman T Klug VJ Zurawski, Int J Cancer 1984 33 3 339 345 10.1002/ijc.2910330310 6199316
40. Carcinoembryonic antigen functions as an accessory adhesion molecule mediating colon epithelial cell-collagen interactions. M Pignatelli H Durbin W Bodmer, Proc Natl Acad Sci USA 1990 87 4 1541 1545 10.1073/pnas.87.4.1541 2304917